Literature DB >> 11557786

Expression of neuro D1 in human normal pituitaries and pituitary adenomas.

K Oyama1, N Sanno, A Teramoto, R Y Osamura.   

Abstract

Neuro D1 is a basic helix-loop-helix transcription factor expressed in the endocrine cells of pancreas and in a subset of neurons as they undergo terminal differentiation. In the adult pituitary gland, Neuro D1 is expressed in corticotroph cells and contributes to the corticotroph-specific pro-opiomelanocortin (POMC) transcription by interacting with Pituitary homeobox 1 (Ptx 1) transcription factor. In the present study, we investigated the expression of Neuro D1 in human normal pituitaries and different types of human pituitary adenomas using the RT-PCR and immunohistochemical techniques. Using RT-PCR, Neuro D1 mRNA was found to be expressed in ACTH-secreting adenomas (n = 3) and 6 of 8 non-functioning adenomas. On the other hand, GH-secreting adenomas (n = 5) and PRL-secreting adenomas (n = 3) were completely negative for Neuro D1 mRNA. Immunohistochemically, Neuro D1 was expressed in all ACTH-secreting adenomas (n = 10), and in 14 of 20 nonfunctioning adenomas. In contrast, 3 of 10 PRL-secreting adenomas and 2 of 10 GH-secreting adenomas showed positive Neuro D1 staining in the nuclei. The above results suggest that Neuro D1 contribute to the functional expression and the differentiation of ACTH-secreting adenomas. It also appears from our study that Neuro D1 might play a role in the differentiation of non-functioning adenomas, the mechanism of which remains to be further investigated. This is the first study on Neuro D1 in case of human pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557786     DOI: 10.1038/modpathol.3880408

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

Review 1.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

Review 2.  Silent corticotroph adenomas.

Authors:  Odelia Cooper
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

3.  Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.

Authors:  Yudo Ishii; Masanori Suzuki; Susumu Takekoshi; Noboru Egashira; Michio Yamazaki; Shunsuke Miyai; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

4.  Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Authors:  Odelia Cooper; Anat Ben-Shlomo; Vivien Bonert; Serguei Bannykh; James Mirocha; Shlomo Melmed
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

5.  Isolation of tumour stem-like cells from benign tumours.

Authors:  Q Xu; X Yuan; P Tunici; G Liu; X Fan; M Xu; J Hu; J Y Hwang; D L Farkas; K L Black; J S Yu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

6.  No mutations in TPIT, a corticotroph-specific gene, in human tumoral pituitary ACTH-secreting cells.

Authors:  L G Bucciarelli; F Pecori Giraldi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

7.  Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease.

Authors:  C de Bruin; J M Hanson; B P Meij; H S Kooistra; A M Waaijers; P Uitterlinden; S W J Lamberts; L J Hofland
Journal:  Endocrinology       Date:  2008-05-15       Impact factor: 4.736

8.  Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1.

Authors:  E Ferretti; D Di Stefano; F Zazzeroni; R Gallo; A Fratticci; R Carfagnini; S Angiulli; A Santoro; G Minniti; G Tamburrano; E Alesse; G Cantore; A Gulino; M L Jaffrain-Rea
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

9.  ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.

Authors:  Masanori Suzuki; Noboru Egashira; Hanako Kajiya; Takeo Minematsu; Susumu Takekoshi; Shigeyuki Tahara; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 10.  Pathology of the human pituitary adenomas.

Authors:  Robert Y Osamura; Hanako Kajiya; Mao Takei; Noboru Egashira; Maya Tobita; Susumu Takekoshi; Akira Teramoto
Journal:  Histochem Cell Biol       Date:  2008-08-08       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.